Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report
Obstetrics & Gynecology Science
; : 69-72, 2019.
Article
em En
| WPRIM
| ID: wpr-719670
Biblioteca responsável:
WPRO
ABSTRACT
Posterior reversible encephalopathy syndrome (PRES) is a newly described adverse effect possibly associated with gonadotropin-releasing hormone (GnRH) agonist therapy. We report a case of PRES after 2 doses of depot GnRH agonists in a 44-year-old woman with a huge myoma uteri and iron-deficiency anemia. Brain magnetic resonance imaging showed high signal lesions in both occipital lobes on fluid-attenuated inversion-recovery (FLAIR) images, compatible with PRES. After treatment with anticonvulsant, she recovered both radiographically and clinically. The association between PRES and GnRH agonist use is still enigmatic, and thus should be further clarified.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Útero
/
Encéfalo
/
Encefalopatias
/
Imageamento por Ressonância Magnética
/
Hormônio Liberador de Gonadotropina
/
Leuprolida
/
Anemia Ferropriva
/
Síndrome da Leucoencefalopatia Posterior
/
Mioma
/
Lobo Occipital
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Obstetrics & Gynecology Science
Ano de publicação:
2019
Tipo de documento:
Article